A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High Risk Current and Former Smokers

Lung cancer chemoprevention, especially in high-risk former smokers, has great potential to reduce lung cancer incidence and mortality. Thiazolidinediones prevent lung cancer in preclinical studies, and diabetics receiving thiazolidinediones have lower lung cancer rates which led to our double-blind...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Prev Res (Phila)
Main Authors: Keith, Robert L., Blatchford, Patrick J., Merrick, Daniel T., Bunn, Paul A., Bagwell, Brandi, Dwyer-Nield, Lori D., Jackson, Mary K., Geraci, Mark W., Miller, York E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6774885/
https://ncbi.nlm.nih.gov/pubmed/31308004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-19-0006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados